DOTA/NOTA/H3RESCA/MAG3/DTPA/Deferoxamine/NTA/Octaaminocryptands
DOTA/NOTA/H3RESCA/MAG3/DTPA/Deferoxamine/NTA/Octaaminocryptands
DOTA、NOTA、H3RESCA 等双功能螯合剂衍生物，用于医学诊疗试剂研发。
DOTA
DOTA 的全名是 1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid，中文名称为 1,4,7,10-四氮杂环十二烷-四乙酸，其中 DO 是 dodecane 的前两个字母，TA 是 tetra acetic acid 中两个单词的首字母。DOTA 中的四个氮原子和以及氮原子上乙酸中的羧基可与金属配位，是一类常用的双功能螯合剂。
-
DO-(CH2COOH)2
-
DO-(CH2COONa)3
-
DO-(CH2COOt-Bu)2
-
DO-(CH2COOt-Bu)3
-
DOTA-(CONH2)3
-
DOTA-(COOt-Bu)3
-
DOTA-(COOt-Bu)3-azide
-
DOTA-(COOt-Bu)3-butyne
-
DOTA-(COOt-Bu)3-C2-NH2
-
DOTA-(COOt-Bu)3-C4-NH2
-
DOTA-(COOt-Bu)3-CH2-Alkynyl
-
DOTA-(COOt-Bu)3-CH2-Ph-azide
-
DOTA-(COOt-Bu)3-Mal
-
DOTA-(COOt-Bu)3-NHFmoc-Lys
-
DOTA-(COOt-Bu)3-NHS
-
DOTA-4AMP
-
DOTA
-
DOTA-Amide
-
DOTA-azide
-
DOTA-Acrylamide
-
DOTA mono-NHS ester
-
DOTA-butyne
-
DOTA-Serotonin
-
DOTA-SH
-
DOTA-BCN
-
DOTA-C2-NH2(TFA salt)
-
DOTA-C4-NH2
-
DOTA-CH2-Alkynyl (TFA salt)
-
DOTA-CH2-Alkynyl(HCl salt)
-
DOTA-CH2-Ph-azide (TFA salt)
-
DOTA-CH2-Ph-azide(HCl salt)
-
DOTA-DBCO
-
DOTAGA2
-
DOTAGA-(COOt-Bu)4
-
DOTATATE
-
(R)-DOTAGA-(COOt-Bu)4
-
(S)-DOTAGA-(COOt-Bu)4
-
DOTA-Maleimide
-
DOTA-Tetrazine
-
DOTA-MeTz
-
DOTA-PEG4-MeTz
-
DOTA-PEG8-NHCO-MeTz
-
DOTA-PEG5-amine
-
DOTA-PEG3-azide
-
DOTA-PEG3-azide（HCl）
-
DOTA-PEG5-azide
-
DOTA-PEG5-C4-DBCO
-
DOTA-p-NCS-Bn
-
DOTA-p-NH2-Bn
-
DOTA-p-NH2-Bn-(COOt-Bu)4
-
DOTA-p-NH2-Bn-biotin
-
DOTA-p-NO2-Bn
-
DOT-Me-Acetic-acid
-
DOTP
-
p-NH2-Bn-oxo-DO3A
-
p-SCN-Bn-oxo-DO3A
-
(N3-PEG4)-(DOTA)-3K
-
1,1',4,4',7,7'-Hexakis(1,1-dimethylethyl) 10,10'-[(5-nitro-1,3-phenylene)bis(methylene)]-Bis[DOTA-(COOt-Bu)3]
-
1,4,7-Tris(1,1-dimethylethyl) 10-[2-[[3,5-bis(methoxycarbonyl)phenyl]amino]-2-oxoethyl]-[DOTA-(COOt-Bu)3]
-
10,10'-[(5-Nitro-1,3-phenylene)bis(methylene)]-(DOTA)2 (HCl salt)
-
10,10'-[(5-Nitro-1,3-phenylene)bis(methylene)]-(DOTA)2 (TFA salt)
-
10-[2-[(3,5-Dicarboxyphenyl)amino]-2-oxoethyl]-DOTA (TFA salt)
-
10-[2-[(3,5-Dicarboxyphenyl)amino]-2-oxoethyl]-DOTA(HCl salt)
-
DOTA-tri(acid)-amido-PEG3-Bromoacetamide
-
Cy7.5-CONH-(C1-CONH-C2-Mal)-C4-DOTA
-
Bromoacetamido-PEG5-DOTA
-
NOTA
-
NOTA-(COOt-Bu)2
-
NOTA-(COOt-Bu)2-Azide
-
NOTA-(COOt-Bu)2-Butyne
-
NOTA-(COOt-Bu)3-Bn-NCS
-
NOTA-Azide
-
NOTA-Bn-Mal
-
NOTA-Butyne
-
NOTA-C6-amine
-
NOTA-NHS ester
-
NOTA-(COOt-Bu)2-C4-NH2
-
NOTA-Tetrazine
-
NOTA-Me-Tetrazine
-
NOTA-GA-Mal
-
NOTA-Maleimide
-
NOTA-PEG8-Mal
-
NO-(COOt-Bu)2
-
(S)-NOTA-GA-(COOt-Bu)3
-
(R)-NOTA-GA-(COOt-Bu)3
-
NOTA-PEG7-N3
-
NOTA-PEG11-N3
-
NOTA-CONH-PEG23-NH-CO-CH2-CH2-Mal
-
NOTA-PEG5000-Mal
-
NOTA-p-NH2-Bn
-
NOTA-p-NCSA-Me-Tetrazine-amine
-
NOTA-p-NCSA-Fmoc-D-赖氨酸
-
NOTA-p-NCSA-DBCO-amine
-
NOTA-p-NCSA-amine-PEG8-azido
-
NOTA-p-NCS-Bn
-
p-NOTA-NCSA
-
NOTP
-
NODA-GA-NHS ester
-
NCS-MP-NODA
-
MeTz-PEG7-NOTA
-
MeTz-PEG11-NOTA
-
Me-Tetrazine-PEG11-NOTA
-
2-[4-(2-hydroxyethyl)-1,4,7-triazonan-1-yl]ethan-1-ol
-
3p-C-NETA-oxa-(tBu)-butanoic acid
-
2p-C-NETA-NCS
-
2C-p-NOTA-Me-Tetrazine
-
2C-p-NOTA-Fmoc-D-赖氨酸
-
2C-p-NOTA-DBCO
-
2C-p-NOTA-PEG8-azido
-
2C-p-NOTA-NCS
-
2C-p-NETA-NCS-Me-Tetrazine-amine
-
2C-p-NETA-NCS-Fmoc-D-赖氨酸
-
2C-p-NETA-NCS-DBCO-amine
-
2C-p-NETA-NCS-amine-PEG8-azido
-
2,2'-(7-(2-((3-(4-Carboxy-1H-1,2,3-triazol-1-yl)propyl)amino)-2-oxoethyl)-1,4,7-triazonane-1,4-diyl)diacetic acid
-
10-[2-[(4-Hydroxy-4,4-diphosphonobutyl)amino]-2-oxoethyl]-1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid
-
10-[2-Oxo-2-[[2-[(1-oxo-3,3-diphosphonopropyl)amino]ethyl]amino]ethyl]-1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid
-
10-[2-[(3,3-Diphosphonopropyl)amino]-2-oxoethyl]-1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid
-
Hexahydro-α1-[3-[(4-hydroxy-4,4-diphosphonobutyl)amino]-3-oxopropyl]-1H-1,4,7-triazonine-1,4,7-triacetic acid
-
Benzamide,N-(2-aminoethyl)-2,5-bis(1,4,8,11-tetraazacyclotetradec-1-ylmethyl)-
-
CB-Cyclam
-
CB-TE2A
-
DiAmSar
-
p-NH2-Bn-PCTA
-
p-SCN-Bn-HEHA
-
p-SCN-Bn-PCTA
-
p-SCN-Bn-TCMC
-
1,4,8,11-Tetraazacyclotetradecane-1,4,8,11-tetraacetic acid
-
2-(Benzoylthio)acetic acid
-
2,5-Bis(1,4,8,11-tetraazacyclotetradec-1-ylmethyl)benzoic acid
-
2,5-bis((4,8,11-tris(tert-butoxycarbonyl)-1,4,8,11-tetraazacyclotetradecan-1-yl)methyl)benzoic acid
-
AMD3100(双-1,4,8,11-四氮杂环十四烷-苯甲酰)-PEG2-Mal
-
AMD3100(双-1,4,8,11-四氮杂环十四烷-苯甲酰)-PEG4-N3
客户近期使用本公司产品发表的高影响因子论文（IF>10）
- Intelligent Nano-Cage for Precision Delivery of CRISPR-Cas9 and ACC Inhibitors to Enhance Antitumor Cascade Therapy Through Lipid Metabolism Disruption
- Multimodal targeting chimeras enable integrated immunotherapy leveraging tumor-immune microenvironment
- A Versatile One-Step Enzymatic Strategy for Efficient Imaging and Mapping of Tumor-Associated Tn Antigen
- Surface-anchored tumor microenvironment-responsive protein nanogel-platelet system for cytosolic delivery of therapeutic protein in the post-surgical cancer treatment
- Genetically Incorporated Non-Canonical Amino Acids
- Boosting Dye-Sensitized Luminescence by Enhanced Short-Range Triplet Energy Transfer
- Global profiling of functional histidines in live cells using small-molecule photosensitizer and chemical probe relay labelling
- Spatiotemporal-resolved protein networks profiling with photoactivation dependent proximity labeling
- A proof-of-concept study on bioorthogonal-based pretargeting and signal amplify radiotheranostic strategy
- Bioengineered Platelets Combining Chemotherapy and Immunotherapy for Postsurgical Melanoma Treatment: Internal Core-Loaded Doxorubicin and External Surface-Anchored Anti-PDL1 Antibody Backpacks
- Scalable Synthesis of Highly Stable Cyclopropene Building Blocks: Application for Bioorthogonal Ligation with Tetrazines
- Noncanonical amino acids as doubly bio-orthogonal handles for one-pot preparation of protein multiconjugates
- Reversible control of tetrazine bioorthogonal reactivity by naphthotube-mediated host-guest recognition
- An Optimized Isotopic Photocleavable Tagging Strategy for SiteSpecific and Quantitative Profiling of Protein O‑GlcNAcylation in Colorectal Cancer Metastasis
西安点化生物科技有限公司独家代理本公司产品,已入驻以下试剂采购平台
可直接点击对应链接跳转下单
